Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023

Detalles Bibliográficos
Autores principales: Akash, Shopnil, Khan, Md. Shajib, Mukerjee, Nobendu, Bibi, Shabana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132295/
https://www.ncbi.nlm.nih.gov/pubmed/36912521
http://dx.doi.org/10.1097/JS9.0000000000000258
_version_ 1785031360605323264
author Akash, Shopnil
Khan, Md. Shajib
Mukerjee, Nobendu
Bibi, Shabana
author_facet Akash, Shopnil
Khan, Md. Shajib
Mukerjee, Nobendu
Bibi, Shabana
author_sort Akash, Shopnil
collection PubMed
description
format Online
Article
Text
id pubmed-10132295
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101322952023-04-26 Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023 Akash, Shopnil Khan, Md. Shajib Mukerjee, Nobendu Bibi, Shabana Int J Surg Editorial Lippincott Williams & Wilkins 2023-03-13 /pmc/articles/PMC10132295/ /pubmed/36912521 http://dx.doi.org/10.1097/JS9.0000000000000258 Text en © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-sa/4.0/This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) , which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/ (https://creativecommons.org/licenses/by-sa/4.0/)
spellingShingle Editorial
Akash, Shopnil
Khan, Md. Shajib
Mukerjee, Nobendu
Bibi, Shabana
Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
title Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
title_full Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
title_fullStr Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
title_full_unstemmed Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
title_short Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023
title_sort re-emergence of sars-cov-2 omicron subvariant xbb.1.5: present status, treatment, and future outlook – 2023
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132295/
https://www.ncbi.nlm.nih.gov/pubmed/36912521
http://dx.doi.org/10.1097/JS9.0000000000000258
work_keys_str_mv AT akashshopnil reemergenceofsarscov2omicronsubvariantxbb15presentstatustreatmentandfutureoutlook2023
AT khanmdshajib reemergenceofsarscov2omicronsubvariantxbb15presentstatustreatmentandfutureoutlook2023
AT mukerjeenobendu reemergenceofsarscov2omicronsubvariantxbb15presentstatustreatmentandfutureoutlook2023
AT bibishabana reemergenceofsarscov2omicronsubvariantxbb15presentstatustreatmentandfutureoutlook2023

Ejemplares similares